HealthVanda says social anxiety drug missed main goal in late-stage study, pauses program
Vanda Pharmaceuticals said Wednesday its experimental social anxiety disorder drug failed to meet the primary goal of a late-stage study. The company has paused the program while it further analyzes the data.
R
Reuters★★☆☆☆2026-10-14 23:45Original
Vanda says social anxiety drug missed main goal in late-stage study, pauses program
Health